We are thrilled to announce the launch of our cutting-edge ampoule filling line at Adragos’ Livron facility in France, marking a transformative milestone in Project Future. This new line is a major investment in enhancing production capacity and furthering our […]
[Munich, October 22nd] – Adragos Pharma, a global Contract Development and Manufacturing Organization (CDMO), is proud to announce its participation in the Science Based Targets initiative (SBTi), marking a significant commitment to environmental sustainability and corporate responsibility in the fight […]
The Adragos Livron site is thrilled to announce two major milestones that are set to redefine our production capabilities and reinforce our commitment to excellence in pharmaceutical manufacturing. Project FUTURE: A New Chapter in Ampoule Production As part of our […]
Adragos Pharma is actively pursuing contract manufacturing in the Japanese market. Leveraging ex-Sanofi’s Kawagoe plant (located Kawagoe City, Saitama Prefecture) which they acquired one year ago as their flagship manufacturing site, they are reinvesting on solid dosage manufacturing to serve […]
We are pleased to announce the strengthening of our long-established partnership with Colonis Pharma. This collaboration exemplifies our commitment to innovation and reliability in pharmaceutical product development and supply. Over a decade ago, our company, then known as Lamda Laboratories, […]
Plettenberg / Munich / Halden, 1st March 2024 – The Prange Group and its affiliate Adragos Pharma, one of Europe’s fastest growing CDMOs, has completed the acquisition transaction of Fresenius Kabi production site in Halden, Norway – a leading sterile […]
Get notified on our latest news.
